Filing Details

Accession Number:
0001209191-20-039978
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-01 21:20:14
Reporting Period:
2020-06-29
Accepted Time:
2020-07-01 21:20:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1545439 Bullaro Lauren Riker C/O Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-29 6,000 $10.34 18,633 No 4 M Direct
Common Stock Disposition 2020-06-29 2,000 $48.72 16,633 No 4 S Direct
Common Stock Disposition 2020-06-29 2,000 $49.34 14,633 No 4 S Direct
Common Stock Disposition 2020-06-29 2,000 $50.34 12,633 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-06-29 6,000 $0.00 6,000 $10.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,180 2021-05-10 No 4 M Direct
Footnotes
  1. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months.